Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Control of mode anticrossings in whispering gallery microresonators.

Werner CS, Sturman B, Podivilov E, Manjeshwar SK, Buse K, Breunig I.

Opt Express. 2018 Jan 22;26(2):762-771. doi: 10.1364/OE.26.000762.

PMID:
29401956
2.

A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population.

Jupe ER, Dalessandri KM, Mulvihill JJ, Miike R, Knowlton NS, Pugh TW, Zhao LP, DeFreese DC, Manjeshwar S, Gramling BA, Wiencke JK, Benz CC.

BBA Clin. 2014 Nov 8;2:94-102. doi: 10.1016/j.bbacli.2014.11.001. eCollection 2014 Dec.

3.

Vitamin D receptor polymorphisms and breast cancer risk in a high-incidence population: a pilot study.

Dalessandri KM, Miike R, Wiencke JK, Farren G, Pugh TW, Manjeshwar S, DeFreese DC, Jupe ER.

J Am Coll Surg. 2012 Nov;215(5):652-7. doi: 10.1016/j.jamcollsurg.2012.06.413. Epub 2012 Aug 4.

PMID:
22867716
4.

Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.

Diergaarde B, Potter JD, Jupe ER, Manjeshwar S, Shimasaki CD, Pugh TW, Defreese DC, Gramling BA, Evans I, White E.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1751-9. doi: 10.1158/1055-9965.EPI-08-0168.

5.

Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk.

Ralph DA, Zhao LP, Aston CE, Manjeshwar S, Pugh TW, DeFreese DC, Gramling BA, Shimasaki CD, Jupe ER.

Cancer. 2007 May 15;109(10):1940-8.

6.

Enhanced motility of KGF-transfected breast cancer cells.

Zang XP, Bullen EC, Manjeshwar S, Jupe ER, Howard EW, Pento JT.

Anticancer Res. 2006 Mar-Apr;26(2A):961-6.

7.

Expression of prohibitin 3' untranslated region suppressor RNA alters morphology and inhibits motility of breast cancer cells.

Manjeshwar S, Lerner MR, Zang XP, Branam DE, Pento JT, Lane MM, Lightfoot SA, Brackett DJ, Jupe ER.

J Mol Histol. 2004 Aug;35(6):639-46.

PMID:
15614618
8.

Oligogenic combinations associated with breast cancer risk in women under 53 years of age.

Aston CE, Ralph DA, Lalo DP, Manjeshwar S, Gramling BA, DeFreese DC, West AD, Branam DE, Thompson LF, Craft MA, Mitchell DS, Shimasaki CD, Mulvihill JJ, Jupe ER.

Hum Genet. 2005 Feb;116(3):208-21. Epub 2004 Dec 21.

PMID:
15611867
9.

Tumor suppression by the prohibitin gene 3'untranslated region RNA in human breast cancer.

Manjeshwar S, Branam DE, Lerner MR, Brackett DJ, Jupe ER.

Cancer Res. 2003 Sep 1;63(17):5251-6.

10.

The regulation of ribonucleoside diphosphate reductase by the tumor promoter orotic acid in normal rat liver in vivo.

Manjeshwar S, Rao PM, Rajalakshmi S, Sarma DS.

Mol Carcinog. 1999 Mar;24(3):188-96.

PMID:
10204803
11.

The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers.

Chen LC, Manjeshwar S, Lu Y, Moore D, Ljung BM, Kuo WL, Dairkee SH, Wernick M, Collins C, Smith HS.

Cancer Res. 1998 Aug 15;58(16):3677-83.

12.

Effect of beta-carotene on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat liver.

Moreno FS, Rossiello MR, Manjeshwar S, Nath R, Rao PM, Rajalakshmi S, Sarma DS.

Cancer Lett. 1995 Sep 25;96(2):201-8.

PMID:
7585458
13.

In vitro and in vivo response of hepatocytes from hepatic nodules to the mitoinhibitory effects of phenobarbital.

Manjeshwar S, Laconi E, Sheikh A, Rao PM, Rajalakshmi S, Sarma DS.

Carcinogenesis. 1994 Sep;15(9):1963-8.

PMID:
7923591
14.

Resistance of hepatic nodules to orotic acid-induced accumulation of uridine nucleotides.

Backway KL, Laconi E, Manjeshwar S, Rao PM, Rajalakshmi S, Sarma DS.

Carcinogenesis. 1994 Feb;15(2):403-6.

PMID:
8313535
15.

Ribonucleotide reductase: a possible target for orotic acid induced mitoinhibition in normal hepatocytes in primary culture.

Manjeshwar S, Pichiri-Coni G, Coni P, Rao PM, Rajalakshmi S, Sarma DS.

Cancer Lett. 1993 Sep 30;73(2-3):149-54. Erratum in: Cancer Lett 1993 Nov 30;75(1):71.

PMID:
8221627
16.

Influence of orotic acid on multistage hepatocarcinogenesis in the rat: resistance of hepatocytes from nodules to the mitoinhibitory effects of orotic acid.

Manjeshwar S, Laconi E, Rao PM, Rajalakshmi S, Sarma DS.

Proc Soc Exp Biol Med. 1993 Jan;202(1):25-9.

PMID:
8424092
17.

Inhibition of DNA synthesis by phenobarbital in primary cultures of hepatocytes from normal rat liver and from hepatic nodules.

Manjeshwar S, Rao PM, Rajalakshmi S, Sarma DS.

Carcinogenesis. 1992 Dec;13(12):2287-91.

PMID:
1473236
18.

Orotic acid, nucleotide-pool imbalance, and liver-tumor promotion: a possible mechanism for the mitoinhibitory effects of orotic acid in isolated rat hepatocytes.

Manjeshwar S, Sheikh A, Pichiri-Coni G, Coni P, Rao PM, Rajalakshmi S, Pediaditakis P, Michalopoulos G, Sarma DS.

Cancer Res. 1992 Apr 1;52(7 Suppl):2078s-2081s.

Supplemental Content

Loading ...
Support Center